Godavari Drugs Limited (BOM:530317)

Market Cap	978.97M +44.4%
Revenue (ttm)	986.94M -22.2%
Net Income	36.92M -40.0%
EPS	4.91 -39.9%
Shares Out	7.53M
PE Ratio	26.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,706
Open	125.65
Previous Close	128.90
Day's Range	125.60 - 135.25
52-Week Range	69.70 - 134.50
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	May 27, 2026

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs L...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 106
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530317

Financial Performance

In fiscal year 2025, Godavari Drugs's revenue was 1.14 billion, a decrease of -27.42% compared to the previous year's 1.57 billion. Earnings were 43.80 million, a decrease of -21.07%.